December 10, 2019

Shaw and Partners Flash Note: “Positive News Flow Continues to Support Outlook; ‘Buy’ Rating; Price Target $3.00”

View Report

View the latest Shaw & Partners Research Update for Cynata Therapeutics

October 18, 2019

Shaw and Partners Flash Note: “Cynata and Sumitomo Withdraw from Acquisition Discussions; ‘Buy’ Rating; Price Target $3.00

View Report

View the latest Shaw & Partners Research Update for Cynata Therapeutics

September 20, 2019

Shaw and Partners Research Update September 19, 2019: “Fujifilm Takes Up its GvHD License Option Providing Commercial Validation of CYP’s Platform”; ‘Buy’ Rating; Price Target $3.00”

View Report

View the latest Shaw & Partners Research Update for Cynata Therapeutics

September 13, 2019

Trading Halt

View Report

July 01, 2019

Shaw and Partners Research Update: “A Key Strategic Position in the Emerging Stem Cell Therapeutic Market; ‘Buy’ Rating; Price Target $2.50”

View Report

View the latest Shaw & Partners Research Update for Cynata Therapeutics